| A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | NCT00951158 |
| NETwork of Linoleic Acid Supplementation in Cystic Fibrosis | Double-blind Randomized Controlled Study of Linoleic Acid Supplementation for 1 Year in Patients With Cystic Fibrosis - Influence on Clinical Status and Metabolism | NCT04531410 |
| The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI=25 | The Effect of 12 Weeks of Conjugated Linoleic Acid on Obesity Markers, Lung Functions, Lipid Profile and Inflammation in Overweight and Obese Women: Double-blind Randomised Control Trial. | NCT04641494 |
| Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | An in Vivo Proof of Principle Trial to Determine Whether the Nutritional Supplement Conjugated Linoleic Acid (CLA, Clarinol™) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | NCT00908791 |
| Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis | Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA/Tonalin® FFA 80) and Probiotics (Vivomixx®/VSL#3) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis | NCT05920018 |
| The Health Benefits of Conjugated Linoleic Acid (CLA) for Asthma & Allergy | Conjugated Linoleic Acid (CLA) as Adjunctive Therapy in Mild Asthmatics: A Pilot Study. | NCT00876356 |
| Conjugated Linoleic Acid and Atherosclerosis | Possible Effects of Supplementation With Cis-9, Trans-11 Conjugated Linoleic Acid on Markers of Atherosclerosis | NCT00706745 |
| A CREAM CONTAINING LINOLEIC ACID, 5%DEXPANTHENOL AND CERAMIDE IN THE TREATMENT OF ATOPIC DERMATITIS | A CREAM CONTAINING LINOLEIC ACID, 5%DEXPANTHENOL AND CERAMIDE IN THE TREATMENT OF ATOPIC DERMATITIS | TCTR20200826001 |
| Bioavailability and metabolic effects in humans of n-3 polyunsaturated fatty acids and conjugated linoleic acid after consumption of naturally enriched cow milk | Bioavailability and metabolic effects in humans of n-3 polyunsaturated fatty acids and conjugated linoleic acid after consumption of naturally enriched cow milk: a randomised double blind parallel group trial | ISRCTN16004121 |
| c9,t11-CLA in Children and Adolescents With Allergic Asthma | Pilot Study on the Effects of Oral Intervention With c9,t11-conjugated Linoleic Acid in Children and Adolescents With Allergic Asthma | NCT01026506 |
| Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body Composition | Dietary Linoleic Acid Regulation of Omega-3HUFA Metabolism: Satiety and Body Composition Among Overweight Female Subjects | NCT01251887 |
| Clinical Efficacy and Safety of Conjugated Linoleic Acid Capsules for Abdominal Obesity | Clinical Efficacy and Safety of Conjugated Linoleic Acid Capsules for Abdominal Obesity | ChiCTR1800016571 |
| Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study) | Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study) | NCT01121471 |
| The effect of weight loss medication, conjugated linoleic acid on body fat in obese individuals. | Randomised Double Blind Prospective Controlled Study Of The Effect Of 12 Weeks Treatment With Conjugated Linoleic Acid Supplementation On Body Fat Mass And Lipid Metabolism In Healthy Obese Individuals | CTRI/2018/04/013289 |
| Metabolic consequences of conjugated linoleic acid supplementation in overweight and obese subjects. | Metabolic consequences of conjugated linoleic acid supplementation in overweight and obese subjects. - CLA and obesity | DRKS00010462 |
| The effect of twelve week conjugated linoleic acid (CLA) supplementation on selected markers of atherosclerosis in obese and overweight women. | The effect of twelve week conjugated linoleic acid (CLA) supplementation on selected markers of atherosclerosis in obese and overweight women. - CLA and atherosclerosis | DRKS00010469 |
| Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome | Effect of the Administration of Conjugated Linoleic Acid / Leucine Plus Metformin on Visceral Fat in Patients With Metabolic Syndrome | NCT02629627 |
| Effect of Conjugated Linoleic Acid supplemented diet on oxidative stress in Chronic Obstructive Pulmonary Disease | Effect of Conjugated linoleic acid supplemented diet on nutritional status, and oxidative stress in Chronic Obstructive Pulmonary Disease patients | IRCT2015080823559N1 |
| The effect of conjugated linoleic acid supplementation in improving of children pulmonary infection | The effect of conjugated linoleic acid supplementation in improving of children pulmonary infection at 1-5 years old in Boali Hospital, Ardabil | IRCT201402235144N6 |
| Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome | Hypocaloric Diet With or Without Microencapsulated Fish Oil or Conjugated Linoleic Acid on Oxidative Stress and Cardiovascular Risk Factors in Women With Metabolic Syndrome Genotyped for Polymorphisms in the Genes PPAR Gamma 2 (Pro12Ala) and Adiponectin (G276T) | NCT02183922 |
| Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | Effect of an Intervention Program With Healthy Habits Plus Metformin or Conjugated Linoleic Acid Over Clinical Parameters and Molecular Pathways of Insulin Resistance in Obese Pediatric Patients | NCT02063802 |
| The effect of conjugated linoleic acid and omega 3 fatty acids on patients with atheroscherosis. | Evaluation the effect of conjugated linoleic acid and omega 3 fatty acids supplements on lipid profile, inflammatory factors and oxidative stress indices on patients with atherosclerosis | IRCT201103146067N1 |
| The Effects of Supplementation of Conjugated Linoleic Acid on Body Fat Reduction | The Effects of Supplementation of Conjugated Linoleic Acid on Body Fat Reduction in Overweight or Obesity Chinese Adults During Weight Loss: A Randomized, Double-blinded, Placebo-controlled Trial | NCT03915808 |
| Comparaison therapiutic effects of congugated linoleic acid with placebo in moderate females acne | Comparaison therapiutic effects of congugated linoleic acid with placebo in moderate females acne | IRCT201302164310N7 |
| CLA and Vitamin D on Protein Turnover | Randomized Controlled Trial to Evaluate the Independent and Combined Effects of Conjugated Linoleic Acids and Vitamin D on Muscle Protein Turnover in Older Adults | NCT03115775 |
| Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS | Phase II Study of Linoleic Acid in Relapsing Multiple Sclerosis | NCT00638196 |
| Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children | Effect of CLA Supplementation on Body Fat Accretion Among Children Who Are Overweight or at Risk of Overweight | NCT00575991 |
| Monocentered, randomised, placebo-controlled, double-blind cross-over study on the effect of Conjugated Linoleic Acid (CLA) on fasting and postprandial metabolic parameters and endothelial function in men with PPAR?2 P12A polymorphism and controls | | ISRCTN91188075 |
| Effect of conjugated linoleic acid on body fat in men with HIV receiving antiretroviral therapy | Effects of a novel dairy fat (Conjugated Linoleic Acid) on body fat in men with HIV receiving highly active Anti-Retroviral Therapy (CLAART): a randomised controlled study | ISRCTN31131566 |
| Older Adult Training Study With Creatine and CLA | Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults | NCT00473902 |
| vitamin D3 and flaxseed oil supplementation effects in type 2 diabetes | Investigation of the effect of high-dose vitamin D3 with alpha linoleic acid (flaxseed oil) supplementation on serum indices of inflammation and oxidative stress in the elderly with type 2 diabetes. | IRCT20161022030424N8 |
| The Effects of NOx and Conjugated Linoleic Acid on Asthmatics | A Proof of Concept Study to Determine the Effects of NOX and Conjugated Linoleic Acid on Asthmatics | NCT02433977 |
| Effect of Conjugated Linoleic Acid Supplement on Body Composition | Conjugated Linoleic Acid and Body Fat Mass in Obese Humans | NCT00347373 |
